Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ninein is a large coiled-coil centrosomal protein encoded by the NIN gene on human chromosome 14. It acts as an anchor for microtubule minus-ends at the subdistal appendages of mother centrioles and the pericentriolar material (PCM), regulating microtubule nucleation and organization. Ninein interacts with γ-tubulin and plays a crucial role in the positioning, stability, and recruitment of microtubule-organizing complexes. In neural and epithelial cells, Ninein supports cell division polarity and stem cell self-renewal by directing asymmetric inheritance of centrosomes. Mutations in NIN cause Seckel syndrome, a congenital disorder characterized by primordial dwarfism and neurodevelopmental deficits. Multiple alternatively spliced isoforms exist and may have tissue-specific roles. Ninein is not considered a direct pharmacological target, but its disruption is implicated in genetic and developmental diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ninein (NIN).